Loading organizations...
Key people at Nobl.
Nobl develops technology solutions designed to enhance patient experience and streamline operations within healthcare settings, primarily through specialized hourly rounding platforms. Its core offering provides healthcare providers with tools for efficient patient engagement, real-time feedback collection, and actionable insights to improve care quality and operational workflows. This system integrates directly into existing hospital infrastructure to foster proactive patient communication and staff accountability, moving beyond traditional manual processes.
Nobl was founded in 2012 by Brett Byman, Katie Hottovy, and Raymond Page, who recognized a critical need for more effective patient engagement strategies in hospitals. Their insight centered on transforming traditional hourly rounding into a data-driven, proactive process that could significantly impact patient satisfaction and staff efficiency. This vision led to the development of their specialized software, which was later acquired by National Research Corporation (NRC Health) on July 15, 2024, integrating its capabilities into a broader suite of healthcare solutions.
The company's solutions serve healthcare organizations, including hospitals and health systems, seeking to elevate patient satisfaction scores and optimize operational performance. Nobl’s foundational vision aimed to empower caregivers with tools to deliver more personalized and responsive care, ultimately fostering better patient outcomes. As part of NRC Health, its mission continues to be focused on leveraging technology to create more meaningful patient and employee experiences within the evolving healthcare landscape, pushing for continuous improvement in care delivery.
Key people at Nobl.
NOBL is the ProShares S&P 500 Dividend Aristocrats ETF, an exchange-traded fund launched on October 9, 2013, that tracks the S&P 500 Dividend Aristocrats Index.[1][3] This equal-weighted index includes S&P 500 companies that have increased their dividends annually for at least 25 consecutive years, currently comprising 69 holdings with stable earnings, solid fundamentals, and strong profitability histories.[1][3][4] As of late 2025, NOBL manages $11.18 billion in assets, features a 0.35% expense ratio, a 2.09% dividend yield (TTM), and top holdings like Cardinal Health (1.87%), Albemarle (1.81%), and C.H. Robinson (1.72%).[1][3]
The ETF's mission centers on delivering consistent dividend growth and lower volatility compared to the broader S&P 500, serving income-focused investors seeking diversification away from high-concentration tech stocks like the Magnificent Seven.[4] Its philosophy emphasizes equal weighting and quarterly rebalancing to mitigate single-stock risk, yielding about 2.5%—higher than standard S&P 500 ETFs—while prioritizing companies with proven resilience.[3][4]
NOBL was introduced by ProShares on October 9, 2013, as the first and only U.S. ETF dedicated to the S&P 500 Dividend Aristocrats Index, created by S&P Dow Jones Indices to spotlight high-quality, dividend-growing large-caps.[1][3][4] ProShares, known for innovative ETF strategies, launched NOBL amid growing demand for income-generating products post-financial crisis, targeting investors wary of market volatility.[1]
The underlying index evolved from the concept of "Dividend Aristocrats," formalized to track S&P 500 firms with 25+ years of annual dividend hikes, with periodic reconstitutions adding stalwarts like Coca-Cola, Procter & Gamble, Walmart, Erie Indemnity, Eversource Energy, and FactSet Research Systems.[4] NOBL's focus has remained steady, adapting to index changes while maintaining its equal-weight structure for balanced exposure.[1][3]
NOBL rides the trend of dividend investing amid tech dominance, countering the S&P 500's heavy reliance on the Magnificent Seven, which drove outsized returns but amplified volatility and concentration risks.[4] Its timing aligns with investor shifts toward quality, resilient names—especially post-2022 rate hikes—favoring stable earners over growth speculation.[4]
Market forces like aging demographics seeking income, potential economic slowdowns, and deglobalization boost Aristocrats' appeal, as these firms span sectors like consumer goods, healthcare, and industrials with global footprints.[3][4] NOBL influences the ecosystem by popularizing equal-weight strategies, inspiring similar funds, and highlighting dividend growth as a benchmark for corporate maturity in a tech-saturated market.[1][4]
NOBL's trajectory points to steady growth for income-oriented portfolios, potentially closing the performance gap with the S&P 500 as interest rates stabilize and value rotates from tech.[4] Rising trends like AI-driven efficiencies in holdings (e.g., FactSet) and sustained dividend cultures could enhance returns, while index expansions maintain its 69-company resilience.[3][4]
Influence may evolve as a core diversifier in multi-asset strategies, with its low-beta profile shining in downturns; expect continued quarterly rebalancing to adapt to Aristocrat additions amid economic cycles. This positions NOBL as a timeless anchor for dividend reliability in volatile markets.[1][3][4]
